Effect of Functional Power Training on Calf Muscle Length & Strength in

Status Recruiting

Clinical Trial Summary

Spastic paresis (SP) is a common motor condition in children and is often caused by cerebral palsy. Skeletal muscles develop differently in children with SP due to brain damage in early development; muscle strength and muscle length are reduced compared to typically developing (TD) children. Especially, the calf muscles are affected, which particularly affects their ability to walk and to run, hindering participation in society. There are several treatments aimed to increase the range of motion of the joint by lengthening the muscle, for example botulinum toxin injections. However, these treatments can have a weakening effect on the muscle due to deconditioning from immobilization and due to paralysis. In rehabilitation centers in the Netherlands functional power training (MegaPower) is offered to children with SP who want to walk and run better. It has been shown that this training improves calf muscle strength and performance during functional walking tests. However, the effect of MegaPower training on muscle morphology (i.a. muscle volume and length) is still unknown. Therefore, the aim of this study is to assess the effect of MegaPower training on the muscle morphology of the medial gastrocnemius in children with SP using 3D ultrasonography. It is expected that MegaPower training results in an increase of muscle volume as well as elongation of the muscle belly. Muscle volume could increase due to hypertrophy of the muscle fibers induced by the training, which could elongate the muscle belly length due to the pennate structure of the medial gastrocnemius. A double-baseline design will be applied for this study with three different measurement times (T0-T1-T2) to compare the training period (12 weeks) with a period (12 weeks) of usual care.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05649930
Study type	Observational
Source	Amsterdam UMC, location VUmc
Contact	Marjolein M van der Krogt, Dr.
Phone	(20)4440789
Email	m.vanderkrogt@amsterdamumc.nl
Status	Recruiting
Phase
Start date	June 20, 2022
Completion date	September 2025

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04530955` - Transitioning to a Valve-Gated Intrathecal Drug Delivery System (IDDS)	N/A
Not yet recruiting	`NCT05131724` - Effectiveness of Virtual Reality on Functional Mobility During Treadmill Training in Children With Cerebral Palsy	N/A
Completed	`NCT03005938` - Influence of the Spinal Manipulation on Muscle Spasticity and Manual Dexterity in Cerebral Palsy.	N/A
Completed	`NCT04087330` - Whole-body Vibration in Spastic Hemiplegic Cerebral Palsy	N/A
Completed	`NCT04570358` - Stretching in Children and Adolescents With Spastic Cerebral Palsy	N/A
Completed	`NCT05945953` - Incentive Spirometer as a Visual Feedback in Children With Spastic Cerebral Palsy	N/A
Completed	`NCT03209310` - The Effect of Trunk Control on Respiratory Muscle Strength	N/A
Recruiting	`NCT03361930` - Changes in Muscle Activity of Children With Spastic Unilat Cerebral Palsy Using 2 Types of Ankle-foot Orthoses to Walk	N/A
Recruiting	`NCT05593887` - Late-presenting Hip Dislocation in Non-ambulatory Children With Cerebral Palsy: A Comparison of Three Procedures	N/A
Recruiting	`NCT03677843` - Multidimensional Approach in Patients With Severe Cerebral Palsy, Prospective Cohort(MAPCP Cohort)-Offline
Recruiting	`NCT03179241` - Outcome After Selective Dorsal Rhizothomy Concerning Life Quality, Cerebral Imaging and Cognition
Not yet recruiting	`NCT06434246` - Effect of Pully System on Hemiplegic Children	N/A
Recruiting	`NCT05627921` - The Effect of Botulinum Toxin and ESWT Applications on Spasticity and Functionality in Cerebral Palsy Patients	N/A
Completed	`NCT05102955` - Turkish Validity and Reliability of the Visual Function Classification System (VFCS)
Recruiting	`NCT06330922` - Muscle-tendon Pathology and Metabolic Dysregulation in CP
Completed	`NCT05251519` - The Efficacy of Derotation Banding on Outcome Measures in Children With Cerebral Palsy	N/A
Completed	`NCT05251532` - The Efficacy of Distortion Banding on Outcome Measures in Children With Cerebral Palsy	N/A
Completed	`NCT05115695` - The Effect of Upper Extremity Strengthening on Functionality, Muscle Strength and Trunk in Children With Cerebral Palsy	N/A
Completed	`NCT04240275` - Reliability of a Body-worn Sensor System for Gait Analysis in Children With CP
Not yet recruiting	`NCT05198921` - The Effectiveness of Repetitive Transcranial Magnetic Stimulation for Spastic Diplegia Cerebral Palsy	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Effect of Functional Power Training on Calf Muscle Length and Strength in Children With Spastic Paresis — MegaMuscle

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms